↓ Skip to main content

Safety and efficacy of bortezomib and melphalan combination in patients with relapsed or refractory multiple myeloma: updated results of a phase 1/2 study after longer follow-up

Overview of attention for article published in Annals of Hematology, May 2008
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (63rd percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

patent
1 patent

Citations

dimensions_citation
35 Dimensions

Readers on

mendeley
23 Mendeley
Title
Safety and efficacy of bortezomib and melphalan combination in patients with relapsed or refractory multiple myeloma: updated results of a phase 1/2 study after longer follow-up
Published in
Annals of Hematology, May 2008
DOI 10.1007/s00277-008-0501-0
Pubmed ID
Authors

James R. Berenson, Hank H. Yang, Robert A. Vescio, Youram Nassir, Russell Mapes, Shi-pyng Lee, Joanna Wilson, Ori Yellin, Blake Morrison, Jacqueline Hilger, Regina Swift

Mendeley readers

The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 4%
Unknown 22 96%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 4 17%
Researcher 4 17%
Other 3 13%
Student > Postgraduate 3 13%
Student > Bachelor 2 9%
Other 7 30%
Readers by discipline Count As %
Medicine and Dentistry 14 61%
Psychology 3 13%
Economics, Econometrics and Finance 2 9%
Agricultural and Biological Sciences 1 4%
Unspecified 1 4%
Other 2 9%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 July 2014.
All research outputs
#2,939,247
of 10,972,625 outputs
Outputs from Annals of Hematology
#99
of 845 outputs
Outputs of similar age
#90,728
of 259,720 outputs
Outputs of similar age from Annals of Hematology
#4
of 28 outputs
Altmetric has tracked 10,972,625 research outputs across all sources so far. This one has received more attention than most of these and is in the 51st percentile.
So far Altmetric has tracked 845 research outputs from this source. They receive a mean Attention Score of 2.3. This one has gotten more attention than average, scoring higher than 58% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 259,720 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.
We're also able to compare this research output to 28 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.